All regulatory updates
894 results found
EPA proposes one-year extension of reporting deadline for TSCA Section 8(d) Health and Safety Data Reporting Rule
EPA proposed to extend the reporting deadline by one year to May 21, 2027 for the one-time TSCA Section 8(d) Health and Safety Data Reporting Rule submissions. If finalized, manufacturers (including importers) and processors subject to the rule would have additional time to compile and submit required unpublished health and safety studies and related information to EPA, affecting internal data-collection, legal review, and submission timelines.
Secretariat invites comments on draft review of specific exemption for perfluorooctyl iodide (PFOI) used to produce perfluorooctyl bromide (PFOB) for pharmaceuticals
The Stockholm Convention Secretariat issued a communication inviting Parties and observers to submit comments on a draft report reviewing the specific exemption covering the use of perfluorooctyl iodide (PFOI) for the production of perfluorooctyl bromide (PFOB) for the purpose of producing pharmaceutical products. The communication sets a comment deadline of 22 May 2026. Compliance teams supporting pharmaceutical supply chains and Parties relying on this exemption should monitor the review outcome, as it may lead to changes to the scope, conditions, or continuation/expiry of the exemption under the Convention’s register of specific exemptions.
Stockholm Convention Secretariat opens comment period on draft review of specific exemption for PFOI→PFOB (pharmaceuticals)
The Stockholm Convention Secretariat published an invitation for Parties and stakeholders to submit comments on a draft report reviewing the specific exemption for the use of perfluorooctyl iodide (PFOI) to produce perfluorooctyl bromide (PFOB) for pharmaceutical products. This consultation may inform whether the exemption is continued, modified, or allowed to expire, which is relevant for pharmaceutical supply chains relying on this specific exemption pathway.
Secretariat opens comment period on draft report reviewing specific exemption for PFOI use to produce PFOB for pharmaceuticals
The Stockholm Convention Secretariat opened an invitation for Parties/observers to submit comments on a draft report reviewing the specific exemption for the use of perfluorooctyl iodide (PFOI) to produce perfluorooctyl bromide (PFOB) for pharmaceutical products. This is a POPs Convention process step that may affect continuation, modification, or expiration of the exemption and therefore future availability of this exemption pathway for regulated entities and supply chains.
Secretariat invitation for comments on draft review of the PFOI→PFOB (pharmaceuticals) specific exemption (deadline 22 May 2026)
The Stockholm Convention Secretariat issued a communication inviting Parties and observers to submit comments on a draft report reviewing the specific exemption for the use of perfluorooctyl iodide (PFOI) to produce perfluorooctyl bromide (PFOB) for pharmaceutical products. The communication sets a comment submission deadline of 22 May 2026. This matters for compliance because outcomes of exemption reviews can change conditions, scope, or continuation/expiry of permitted uses for Annex-listed POPs and may require companies supporting registered uses to adjust sourcing, product formulations, or documentation supporting continued lawful use in Parties relying on the exemption.
Secretariat invites comments on draft review of PFOI→PFOB (pharmaceuticals) specific exemption (deadline 22 May 2026)
The Stockholm Convention Secretariat issued an invitation to submit comments on a draft report reviewing the specific exemption for the use of perfluorooctyl iodide (PFOI) to produce perfluorooctyl bromide (PFOB) for the production of pharmaceutical products. The communications listing specifies a comment deadline of 22 May 2026. Compliance teams should monitor this exemption review because the outcome can change the continued availability/conditions of the exemption and may trigger updates to national implementation measures for affected pharmaceutical supply chains.
Stockholm Convention Secretariat opens call for comments on draft review of PFOI→PFOB (pharmaceuticals) specific exemption
The Stockholm Convention Secretariat posted an invitation for Parties and stakeholders to submit comments on a draft report reviewing the specific exemption for use of perfluorooctyl iodide (PFOI) to produce perfluorooctyl bromide (PFOB) for the purpose of producing pharmaceutical products. Compliance teams in affected supply chains (fluorochemicals and pharma intermediates) should review the draft review report and submit technical/economic information within the stated comment window, as outcomes can inform whether the exemption is continued, modified, or allowed to expire in future COP decisions.
Secretariat invites comments on draft review of specific exemption for PFOI use to produce PFOB for pharmaceuticals (deadline 22 May 2026)
The Stockholm Convention Secretariat opened a comment process on a draft report reviewing the specific exemption for using perfluorooctyl iodide (PFOI) to produce perfluorooctyl bromide (PFOB) for producing pharmaceutical products. The research text states a submission deadline of 22 May 2026. Compliance teams should assess whether they rely on (or may rely on) this exemption pathway and consider submitting technical input, as the review could affect continuation, conditions, or scope of the exemption.
USGBC Consolidates LEED Appeal Fees to Single Flat Rate
Effective March 27, 2026, USGBC consolidated supplemental review (appeal) fees into a single flat fee for all credits, eliminating the previous tiered structure that had separate fees for 'simple' versus 'complex' credits. This simplifies the fee structure for project teams seeking to appeal credit review decisions.
OAL approves first readoption of CARB emergency vehicle emissions regulations; filed March 26, 2026 with effective April 1, 2026 and expiration July 1, 2026
CARB’s emergency vehicle emissions rulemaking page indicates the Office of Administrative Law (OAL) approved the first readoption of the emergency vehicle emissions regulations and that the readoption was filed with the Secretary of State on March 26, 2026. CARB states the readopted emergency regulations become effective April 1, 2026 and will expire July 1, 2026. Compliance teams impacted by these emergency vehicle emissions provisions should account for the operative window through July 1, 2026 and monitor subsequent readoptions or permanent rulemaking.
ECHA opens consultation on SEAC draft opinion for EU-wide PFAS REACH restriction (26 Mar–25 May 2026)
ECHA opened a stakeholder consultation to submit information on the draft Socio-Economic Analysis Committee (SEAC) opinion for the proposed EU-wide REACH restriction on per- and polyfluoroalkyl substances (PFAS). Companies affected by potential PFAS use restrictions should review the draft opinion context, assess impacts/alternatives/derogation needs, and submit socio-economic and technical evidence before the consultation closes (25 May 2026).
ECHA launches 60-day consultation on SEAC draft opinion for EU-wide PFAS REACH restriction (universal PFAS proposal)
ECHA materials for the EU-wide ("universal") PFAS restriction under REACH indicate that consultation on SEAC’s draft opinion opened on 26 March 2026 and runs for 60 calendar days. This is a key milestone in the restriction process and a near-term action point for companies and associations to submit technical and socio-economic information (uses, alternatives, costs, emissions) relevant to potential restriction conditions and transition periods across affected sectors.
ECHA opens 60-day consultation on SEAC draft opinion for EU-wide PFAS restriction; RAC opinion adopted
ECHA opened a 60-day stakeholder consultation on SEAC’s draft opinion related to the proposed EU-wide REACH restriction on PFAS (universal PFAS proposal). ECHA communications also confirm RAC has adopted its opinion on the restriction proposal and that the committees support an EU-wide restriction with targeted derogations and risk-management measures for derogated uses. Compliance teams should use the open consultation window to submit technical and socioeconomic evidence, especially regarding use essentiality, alternatives, transition timelines, and emission minimisation/management measures that could become conditions of any future restriction.
ECHA opens consultation on SEAC draft opinion for EU-wide PFAS restriction (26 Mar–25 May 2026)
ECHA opened a public consultation on the Committee for Socio-Economic Analysis (SEAC) draft opinion in the ongoing REACH restriction process for an EU-wide PFAS restriction proposal. Compliance teams tracking the proposed PFAS restriction should consider participating in the consultation (e.g., providing socio-economic information, use/alternatives data) and monitor subsequent RAC/SEAC opinion finalisation steps that will inform any eventual Commission restriction decision.
ECHA supports PFAS restriction with targeted derogations (REACH restriction process update)
ECHA posted an official process update indicating support for the proposed EU-wide PFAS restriction under REACH, including discussion of targeted derogations. While not a final legal restriction, this type of update is relevant for compliance teams because it signals likely scope/derogation direction and helps companies anticipate which uses may face bans, conditions, or transition periods in a future Annex XVII restriction.
Hong Kong gazettes commencement dates to control eight COP5 mercury-added product categories under Mercury Control Ordinance
Hong Kong issued a commencement notice (gazetted 26 March 2026) to bring into force new/expanded controls under the Mercury Control Ordinance (Cap. 640) for eight mercury-added product categories adopted under Minamata Convention COP5 amendments. The notice sets staged commencement (prohibition on manufacture/import/export after commencement, with limited allowances as specified) including: 27 March 2026 for certain button zinc silver oxide/zinc air batteries with mercury content <2 wt% and certain high-accuracy measurement bridges and RF switches/relays (≤20 mg Hg) and certain cosmetics (with specified trace/preservative exceptions); 31 December 2026 for specified compact fluorescent and halophosphate fluorescent lamps; and 31 December 2027 for specified triband phosphor fluorescent lamps. A grace period for supply/sale is stated through 31 January 2029, after which supply may be prosecuted. This is a jurisdictional implementation action aligning Hong Kong controls with Minamata COP5 Annex A changes (and related applicability for PRC/HKSAR).
SEAC agrees draft opinion on PFAS restriction proposal (committee milestone)
ECHA posted an official update that its Socio-Economic Analysis Committee (SEAC) agreed its draft opinion on the PFAS restriction proposal under REACH. This signals progression toward final RAC/SEAC opinions and eventual European Commission decision-making for an Annex XVII restriction. Compliance teams should use these committee milestones to accelerate PFAS inventory mapping, use-case justification, and substitution roadmaps aligned to likely restriction parameters and derogations.
ECHA announces consultation to be launched on draft SEAC opinion for PFAS restriction (process consultation notice)
ECHA posted an official notice indicating it would launch a consultation on the draft SEAC (Socio-Economic Analysis Committee) opinion for the proposed EU-wide PFAS restriction under REACH. This is a key milestone in the restriction process: companies affected by potential PFAS restrictions should monitor the consultation window and prepare technical and socio-economic input to support derogation requests, transition periods, or alternative-risk-management arguments.
EPA proposes extending compliance dates in TSCA Section 6 risk management rules for perchloroethylene (PCE) and carbon tetrachloride (CTC)
EPA released a proposal to extend certain compliance dates in the final TSCA Section 6 risk management rules for perchloroethylene (PCE) and carbon tetrachloride (CTC) while EPA works on further rule revisions. EPA states it is not revisiting the underlying TSCA unreasonable risk determinations and that protections are not being weakened. EPA indicates a 30-day public comment period will run upon Federal Register publication and points stakeholders to the rulemaking docket via Regulations.gov, which compliance teams should monitor for the Federal Register notice, specific extended dates, and applicability details.
EPA proposes extending certain compliance dates in TSCA Section 6 risk management rules for perchloroethylene (PCE) and carbon tetrachloride (CTC)
EPA announced a proposal to extend certain compliance dates in the final TSCA Section 6 risk management rules for perchloroethylene (PCE) and carbon tetrachloride (CTC) to improve practical implementation (including Workplace Chemical Protection Program-related timelines). Until any amendments are finalized, currently-effective compliance dates remain in effect. EPA is seeking public comment via docket EPA-HQ-OPPT-2026-0992 on Regulations.gov.